Ghemaxan

Ghemaxan is an anticoagulant medication containing Enoxaparin Sodium, used to prevent and treat blood clots. It is suitable for haemodialysis, intravenous, and subcutaneous use.

Ghemaxan is primarily used to prevent and treat blood clots in various medical conditions. It is often administered to patients undergoing haemodialysis or those at risk of deep vein thrombosis. The medication works by thinning the blood, reducing the likelihood of clot formation. Healthcare professionals may also prescribe Ghemaxan for other conditions where anticoagulation is necessary.

Common effects of Ghemaxan may include bruising, bleeding, and pain at the injection site. Some users might experience allergic reactions or unusual bleeding. It is important to monitor for any signs of excessive bleeding, as this could indicate an adverse reaction to the medication.

Ghemaxan should be handled with care to avoid accidental injury. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients with a history of bleeding disorders or those taking other blood-thinning medications should use Ghemaxan with caution. Always inform your healthcare provider about any other medications you are taking.

Ghemaxan may interact with other medications, including blood thinners, NSAIDs, and certain antibiotics. Alcohol consumption should be avoided as it can increase the risk of bleeding. Always consult a healthcare professional before starting or stopping any medication while using Ghemaxan.